A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,936 shares of EYPT stock, worth $22,438. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,936
Previous 1,555 24.5%
Holding current value
$22,438
Previous $13,000 15.38%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$7.58 - $10.54 $2,887 - $4,015
381 Added 24.5%
1,936 $15,000
Q2 2024

Jul 30, 2024

BUY
$8.16 - $22.89 $12,688 - $35,593
1,555 New
1,555 $13,000
Q4 2023

Jan 24, 2024

BUY
$5.71 - $24.13 $5,036 - $21,282
882 Added 6.0%
15,584 $360,000
Q3 2023

Oct 26, 2023

BUY
$7.99 - $15.36 $117,468 - $225,822
14,702 New
14,702 $117,000
Q3 2022

Nov 10, 2022

BUY
$6.96 - $11.12 $78,905 - $126,067
11,337 New
11,337 $90,000

Others Institutions Holding EYPT

About EyePoint Pharmaceuticals, Inc.


  • Ticker EYPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,072,200
  • Market Cap $395M
  • Description
  • EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...
More about EYPT
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.